biotech
Heart Drug Trasylol May Boost Risk of Death
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on October 30, 2007
Foolowing the results of the a study on the efficacy and safety of Trasylol, a drug used to prevent excessive bleeding during heart bypass surgery, the FDA issued a warning that the drug also raises the risk of death in comparison to other drugs. Trasylol, also known as aprotinin, works by blocking enzymes that dissolve blood clots

trasylol.JPG


Bayer said it believes Trasylol remains a safe and effective treatment option, but that the company would work with the FDA and regulators in other countries to re-evaluate the drug's risks and benefits and determine where any label changes are needed.

The FDA said such changes, as well as other, unspecified regulatory actions, may result.


Source: Fox News



Permalink: Heart Drug Trasylol May Boost Risk of Death
Tags: FDA  heart+disease  trasylol  heart+surgery  heart+bypass  biotech  risk+death  drug+trasylol 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/99501
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Heart Drug Trasylol May Boost Risk of Death:

  • Currently 9.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.00 out of 1 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!